According to new government data released Wednesday morning, drug overdose fatalities in the U.S. decreased last year to the lowest rate recorded since 2019.
The preliminary data from the CDC and NCHS indicated that national drug overdose fatalities decreased from 110,037 to 80,391 in 2024 from the previous year. This signifies a reduction of nearly 27% and the lowest yearly drug overdose death toll in five years, as per the data.
The drug overdose deaths have decreased for the second successive year after a period of annual rises since the COVID-19 epidemic, prompting experts to express optimism over this trend.
Dr Petros Levounis, a professor and head of the psychiatry department at Rutgers New Jersey Medical School, who did not contribute to the report, suggested that the current situation warrants cautious optimism. He explained that the data indicates a near reversion to pre-pandemic levels of overdose fatalities.
The analysis revealed that the largest decrease in drug-related mortality occurred in the synthetic opioid category, which includes fentanyl, with a decrease from 76,282 to 48,422 fatalities between the two years in question.
There were also reductions in overdose fatalities associated with psychostimulants, including cocaine, as well as natural or semi-synthetic substances like morphine.
Moreover, almost every state nationwide saw reductions in drug overdose deaths. The research indicates that Virginia, Louisiana, New Hampshire, Michigan, Ohio, West Virginia, Washington, D.C. and Wisconsin all had decreases of at least 35% from 2023 to 2024. In contrast, Nevada and South Dakota had just slight rises in the rates.
With that said, experts have noted that public health authorities need to focus on Alaska, where opioid overdose cases have consistently risen for the past seven years. The CDC data attributes these high levels to a rapid increase in the amount of fentanyl.
As per the CDC, fentanyl is approximately 50 times stronger than heroin and 100 times deadlier than morphine, and it may be lethal even in little quantities. Other substances may be adulterated with lethal concentrations of fentanyl, which a user cannot detect via sight, taste, or smell.
Experts assert that they identify many factors contributing to the decline in overdose fatalities. One of them is the increased prevalence of naloxone, a substance used to reverse overdoses.
In March 2023, the U.S. FDA authorized Narcan for over-the-counter distribution.
Narcan, produced by Emergent BioSolutions, is administered as a nasal spray, and naloxone (the active component of the drug) can rapidly reinstate breathing in those undergoing an opioid overdose; however, its effects are brief, and some individuals may need further doses.
Harm reduction organizations and various experts advocate for improved access to naloxone as a measure to mitigate the huge amounts of overdose fatalities that occur annually in the U.S.
